| Cisplatin investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 485show all (up to 200) |
|---|
| → investigated in trials for | Lung Non-Small Cell Carcinomasubtype 345 trials (111 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Lung Non-Small Cell Carcinoma | 345 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Head and Neck Neoplasm 168 trials (18 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Head and Neck Neoplasm | 168 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Lung Neoplasm 149 trials (19 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Lung Neoplasm | 149 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Cervical Neoplasmcancer 136 trials (30 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Cervical Neoplasm | 136 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Head and Neck Squamous Cell Carcinomasubtype 111 trials (46 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Head and Neck Squamous Cell Carcinoma | 111 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Gastric Neoplasmcancer 94 trials (9 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Gastric Neoplasm | 94 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nasopharyngeal Carcinoma 93 trials (44 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Nasopharyngeal Carcinoma | 93 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Esophageal Neoplasmcancer 90 trials (9 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Esophageal Neoplasm | 90 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Bladder Neoplasmcancer 81 trials (19 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Bladder Neoplasm | 81 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lung Small Cell Carcinoma 74 trials (20 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Lung Small Cell Carcinoma | 74 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Ovarian Neoplasmcancer 60 trials (15 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Ovarian Neoplasm | 60 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Breast Neoplasm 59 trials (8 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Breast Neoplasm | 59 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Solid Neoplasm 58 trials (21 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Solid Neoplasm | 58 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Pancreatic Neoplasmcancer 54 trials (11 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Pancreatic Neoplasm | 54 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Esophageal Squamous Cell Carcinomasubtype 47 trials (17 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Esophageal Squamous Cell Carcinoma | 47 | Observed | clinicaltrials | graph → |